2025 In Review - Neuromuscular Disorders

This comprehensive review synthesizes high-impact research and clinical developments within the field of neuromuscular disorders throughout 2025. The paper details significant breakthroughs in therapeutic interventions, including novel gene therapies, complement inhibitors, and immune-modulating agents for conditions such as ALS and Myasthenia Gravis. It highlights updated clinical guidelines and the increasing utility of biomarkers to improve diagnostic accuracy and patient monitoring. Furthermore, the sources examine the role of global registries and the necessity of addressing demographic disparities to ensure equitable access to emerging treatments. Ultimately, the collection illustrates a shift toward precision medicine and individualized care for patients facing complex neurological challenges.